Dementia risk assessment scales show variable predictive performance across scores, baseline age, and follow-up duration, and may be useful for dementia risk stratification in clinical practice, and may be useful for dementia risk stratification in clinical practice.
Abstract
In our systematic review and meta-analysis, we aimed to assess the predictive accuracy and clinical applicability of ten dementia risk assessment scores for incident dementia in cohort studies. Three of 10 risk scores had sufficient, comparable data for a meta-analysis. We analyzed the Cardiovascular Risk Factors Ageing and Dementia (CAIDE), Lifestyle for brain health (LIBRA), and Alzheimer's Disease Risk Index (ANU-ADRI) in middle- and older-aged baseline populations with short, medium, and long follow-up durations, starting free from dementia, with or without other health conditions. A total of 29 studies met our inclusion criteria; 13 were included in the meta-analyses. CAIDE performed best, particularly among middle-aged participants at baseline, with longer follow-up periods, yielding pooled areas under the curves (AUCs) of 0.74-0.76. ANU-ADRI showed stable, moderate predictive accuracy with AUCs of approximately 0.65-0.71. The original LIBRA showed the lowest discrimination, with AUCs ranging from 0.51 to 0.60, whereas the modified LIBRA performed better, with AUCs of 0.65-0.67 at short follow-up and a pooled AUC of 0.70 (95% CI 0.66-0.74) at medium follow-up. Dementia risk assessment scales show variable predictive performance across scores, baseline age, and follow-up duration, and may be useful for dementia risk stratification in clinical practice. As a substantial proportion of dementia risk is linked to potentially modifiable factors, identifying high-risk individuals may help guide timely risk-reduction strategies. Further prospective validation is needed across different populations and clinical settings.
Abstract Introduction Anxiety is among the earliest and most common neuropsychiatric symptoms in cognitive impairment. Emerging evidence suggests that anxiety may elevate the risk of cognitive decline in mild cognitive impairment (MCI). This systematic review and meta-analysis was performed to quantitatively synthesize...
D. Fresnais, Brynjar Fure· Dementia and Geriatric Cogni...· 0 citations
Up to 45% of dementia can be prevented by addressing modifiable risk factors. Brain Health Services (BHS) are emerging across Europe, targeting individuals with subjective cognitive decline (SCD) to assess, communicate and reduce their risk of dementia. Our aim is to characterize our BHS cohort, and assess differences...
F. E. Pozzi, Francesca Solivani, I. Vitagliano et al.· Neurological Sciences· 0 citations
Apathy is a robust and consistent behavioral predictor of progression from MCI to clinical AD dementia, and domain-specific neuropsychiatric assessment may improve future risk stratification.
Yu-Ying Sun, Yu Cao, Jin-Ye Ma et al.· International Psychogeriatri...· 1 citation
This systematic review evaluated longitudinal evidence on the association between MBI and incident dementia, including conversion rates, dementia subtypes, domain-specific risk patterns, and biomarker correlates, finding MBI seems to represent a clinically meaningful syndrome that identifies individuals at elevated ris...
K. L. M. Sassi, A. Thomson, Vanessa M. Young et al.· Journal of Alzheimer's Disea...· 0 citations
The association between BD and increased dementia risk was observed across the examined subgroups and substantial between-study heterogeneity and the limited evidence available for specific dementia subtypes warrant cautious interpretation of the pooled estimates.
Zi-Han Gao, Mei-Ling Ren, Rui-Ji Yang et al.· Frontiers in Aging Neuroscie...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.